Sybleu Inc. Stock

SYBE

US87114K1051

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 21:06:04 15/07/2024 +04			5-day change	1st Jan Change
0.0550 ^USD	+8.91%		-.--%	-

18/04/24	Worldwide Holdings, LLC acquired 58.5% stake in Sybleu Inc. from Joseph Vaini and Harry Lander for $1.	CI
24/01/24	Sybleu Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

SYBLEU Inc. is engaged in the acquisition, licensing and development of medical and veterinary applications. The Company is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The Company is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical diagnostics. It is also involved in the development of disposable medical devices. The Company has completed Phase I and or Phase II clinical trials, after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
SYBE Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	531K 464K 429K 396K 746K 50.97M 759K 5.11M 2.01M 24.96M 1.99M 1.95M 85.94M	P/E 2022 *	-	P/E 2023	-16.6x
Enterprise Value	1M 878K 811K 750K 1.41M 96.48M 1.44M 9.68M 3.8M 47.24M 3.77M 3.69M 163M	EV / Sales 2022 *	-	EV / Sales 2023	298,725,376x
Free-Float	92.39%	Yield 2022 *	-	Yield 2023	-

18/07/23	Sybleu Inc. Describes Competitive Landscape Around Artificial Intelligence and Machine Learning in Small Molecule Drug Discovery	PR
12/07/23	Wednesday's OTC Penny Stocks On the Rise (SYBE, ZRFY, HYSR, HNRC)	AQ
12/07/23	Wednesday's OTC Penny Stocks On the Rise:SYBE, SRFY, HYSR, HNRC	AQ
11/07/23	Sybleu Inc. Purchases Fifty Percent Stake In Patent Protected Small Molecule Therapeutic Compounds, Anticipates Synergy With Recently In-Licensed AI/ML Engine	PR
27/06/23	Sybleu Inc. Obtains Exclusive License for Artificial Intelligence/ Machine Learning Small Molecule Drug Design Engine	PR

3 years	0.01	0.15
5 years	0.01	0.29
10 years	0.01	0.29

Manager	Title	Age	Since
Jeremy Davey CEO	Chief Executive Officer	-	12/04/2024
Laman P. Milner PSD	President	-	12/04/2024
John Clark SEC	Corporate Secretary	-	12/04/2024

Director	Title	Age	Since
Laman P. Milner BRD	Director/Board Member	-	12/04/2024
Jeremy Davey CHM	Chairman	-	12/04/2024
John Clark BRD	Director/Board Member	-	12/04/2024

Sybleu Inc. Stock

Stocks

SYBE

US87114K1051

Pharmaceuticals

Valuation: Sybleu Inc.

Latest news : Sybleu Inc.

Press Releases: Sybleu Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Sybleu Inc.

Specialty & Advanced Pharmaceuticals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SYBLEU INC.	+8.91%	-.--%	-.--%	-47.62%	584K
MERCK & CO., INC.	-2.62%	-6.27%	+44.35%	+12.52%	306B
MERCK KGAA	-0.25%	-2.31%	+23.67%	-6.28%	69.32B
HALOZYME THERAPEUTICS, INC.	-1.39%	-7.99%	+30.18%	+96.36%	9.03B
KYOWA KIRIN CO., LTD.	+1.16%	-2.74%	+7.28%	+2.31%	8.48B
SK BIOPHARMACEUTICALS CO., LTD.	-5.93%	-11.19%	-24.11%	-1.45%	4.16B
BETTA PHARMACEUTICALS CO., LTD.	+8.22%	+1.63%	+20.93%	+34.83%	4B
YUHAN CORPORATION	-2.06%	-4.17%	-40.29%	+18.10%	3.4B
SUPERNUS PHARMACEUTICALS, INC.	-1.46%	-2.67%	+37.40%	+55.38%	2.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+1.57%	-1.94%	+12.52%	-19.39%	2.15B
Average	+0.40%	+2.77%	+11.19%	+14.48%	40.96B
Weighted average by Cap.	-2.20%	-3.97%	+37.93%	+11.22%

	2022	2023
Net sales	0.01 0.01 0.01 0.01 0.02 1.12 0.02 0.11 0.04 0.55 0.04 0.04 1.89	0.01 0.01 0.01 0.01 0.02 1.12 0.02 0.11 0.04 0.55 0.04 0.04 1.89
Net income	-245K -214K -198K -183K -345K -23.57M -351K -2.36M -927K -11.54M -922K -901K -39.73M	-180K -158K -146K -135K -253K -17.32M -258K -1.74M -682K -8.48M -677K -662K -29.2M
Net Debt	73.15K 63.93K 59.09K 54.6K 103K 7.03M 105K 705K 276K 3.44M 275K 269K 11.85M	474K 414K 383K 354K 666K 45.5M 678K 4.56M 1.79M 22.28M 1.78M 1.74M 76.72M